Several abstracts based on NCDR data will be presented during ACC's Annual Scientific Session (ACC.18) in Orlando, March 10 – 12. Expanding on previous years, these abstracts highlight the role of NCDR registries in practice-changing clinical research:

ACTION Registry

• Predicting the Need For Skilled Nursing Facilities After Acute Myocardial Infarction
  Jason H. Wasfy, MD, MPhil, FACC
  Saturday, March 10, 10 – 10:45 a.m.
  Poster Hall, Hall A/B

• Association of Pre-Activation of the Cardiac Catheterization Laboratory on Reperfusion Timing Metrics For Patients With STEMI Undergoing Primary PCI: A Report From ACTION Registry
  Jay Shavadia, MB BCh
  Monday, March 12, 8:51 – 9:01 a.m.
  Room 205 A

• Regionalization of STEMI Care in ACTION: National and International Perspectives
  James G. Jollis, MD, FACC
  Monday, March 12, 1:31 – 1:40 p.m.
  Room 304 E

CathPCI Registry

• Use and Effectiveness of Manual Aspiration Thrombectomy During PCI For the Treatment of STEMI in the U.S.: An Analysis From the NCDR CathPCI Registry
  Eric Alexander Secemsky, MD
  Saturday, March 10, 10 – 10:45 a.m.
  Poster Hall, Hall A/B

• Comparison of Rates of Bleeding and Vascular Complications Before, During and After Trial Enrollment in the SAFE-PCI Trial For Women
  Jennifer Rymer, MD
  Saturday, March 10, 3:45 – 4:30 p.m.
  Poster Hall, Hall A/B

• Current Landscape of Hybrid Revascularizations: A Report From the NCDR
  Angela Lowenstern, MD
  Saturday, March 10, 4:15 – 4:25 p.m.
  Interventional Cardiology Moderated Poster Theater, Poster Hall, Hall A/B

• Uptake and Utilization of Drug-Eluting Bioresorbable Vascular Scaffolds: A CathPCI Registry Study
  Ajay J. Kirtane, MD, FACC
  Sunday, March 11, 8:38 – 8:48 a.m.
  Room 204 C

• Ad Hoc PCI in Patients With Stable Coronary Artery Disease: A Report From the NCDR
  Kamil Faridi, MD
  Monday, March 12, 9:45 – 10:30 a.m.
  Poster Hall, Hall A/B

Diabetes Collaborative Registry

• Real-World Opportunity of Empagliflozin in Cardiovascular Risk Factor Modification: An NCDR Research-to-Practice Project From the Diabetes Collaborative Registry
  Suzanne Arnold, MD
  Sunday, March 11, 10 – 10:10 a.m.
  Prevention Moderated Poster Theater, Poster Hall, Hall A/B

• Eligibility Varies Across the 3 Sodium-Glucose Cotransporter-2 Inhibitor Cardiovascular Outcomes Trials Among Adults With Type 2 Diabetes: Implications From Analysis of the Diabetes Collaborative Registry
  Eric Wittbrodt, PharmD
  Sunday, March 11, 4:15 – 4:25 p.m.
  Prevention Moderated Poster Theater, Poster Hall, Hall A/B

PINNACLE Registry

• Reducing Cardiovascular Risk in the Medicare Million Hearts Risk Reduction Model
  William Borden, MD, FACC
  Sunday, March 11, 10:15 – 10:25 a.m.
  Prevention Moderated Poster Theater, Poster Hall, Hall A/B

• Guideline-Recommended Patient Education Among Outpatients With Heart Failure: Results From the NCDR PINNACLE Registry
  Karl E. Minges, PhD, MPH
  Monday, March 12, 10:15 – 10:25 a.m.
  Prevention Moderated Poster Theater, Poster Hall, Hall A/B

• Management of Resistant Hypertension and Implications of PATHWAY-2 Trial in U.S. Cardiology Practice: Insights From NCDR PINNACLE Registry
  Lauren Thompson, MD
  Monday, March 12, 1:15 – 1:25 p.m.
  Prevention Moderated Poster Theater, Poster Hall, Hall A/B

STS/ACC TVT Registry

• The Effect and Relationship of Age and Frailty on Survival in Patients Undergoing TAVR
  Soroosh Kiani, MD
  Saturday, March 10, 10 – 10:10 a.m.
  Interventional Cardiology Moderated Poster Theater, Poster Hall, Hall A/B

• Outcomes After Transcatheter Mitral Valve Repair in Patients With Chronic Kidney Disease: An Analysis of 5,241 Patients in the U.S.
  Binita Shah, MD, FACC
  Saturday, March 10, 10 – 10:45 a.m.
  Poster Hall, Hall A/B

• High Hospital Variability in Mortality After TAVR Can be Explained by Differences in Failure to Rescue From Post-Procedural Complications
  Muath Bishawi, MD
  Saturday, March 10, 10:30 – 10:40 a.m.
  Interventional Cardiology Moderated Poster Theater, Poster Hall, Hall A/B

• Outcomes Following Urgent/Emergent TAVR: Insights From the STS/ACC TVT Registry
  Dhaval Kolte, MD, PhD
  Sunday, March 11, 1:15 – 1:25 p.m.
  Interventional Cardiology Moderated Poster Theater, Poster Hall, Hall A/B

• Atrial Fibrillation Is Associated With Higher Rates of Death and Heart Failure Hospitalizations in Patients Undergoing MitraClip: Outcomes From the TVT Registry
  Sameer Arora, MD
  Monday, March 12, 9:45 – 10:30 a.m.
  Poster Hall, Hall A/B

Keywords: ACC18, ACC Annual Scientific Session, Coronary Artery Disease, Atrial Fibrillation, Diabetes Mellitus, Type 2, Skilled Nursing Facilities, Outpatients, Mitral Valve, Transcatheter Aortic Valve Replacement, Registries, Hypertension, Thrombectomy, Percutaneous Coronary Intervention, Cardiac Catheterization, Risk Reduction Behavior, National Cardiovascular Data Registries, CathPCI Registry, STS/ACC TVT Registry, ACTION Registry, ICD Registry, PINNACLE Registry, IMPACT Registry

< Back to Listings